Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Syntagon

Syntagon
1998 FOUNDED
M&A STATUS
1-10 EMPLOYEES
Buyout/LBO LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Manufacturer and developer of drugs and chemicals. The company involved in contract development and manufacturing organization (CDMO) and testing pharmaceutical ingredients supporting clinical trials and launched products.

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Box 2073
  • 151 02 Södertälje
  • Sweden

+46 08-554 000 00

Syntagon Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Syntagon‘s full profile, request access.

Request full access to PitchBook

Syntagon Executive Team (2)

Name Title Board
Seat
Contact
Info
Michael Lofthagen Chief Executive Officer & Co-Founder
Paul Alhadeff Co-Founder & General Manager